Medicine
Fibryga 20 mg/mL powder for injection
Fibryga 20 mg/mL powder for injection is a prescription medicine containing Fibrinogen human for intravenous use, marketed by Octapharma, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Do not freeze. Store FIBRYGA for up to 48 months at +2°C to + 25°C (36°F to…
Key facts
- Active ingredient (INN)
- Fibrinogen human
- Brand
- Fibryga
- Strength
- 20 mg/mL
- Dosage form
- Powder for injection
- Route
- Intravenous
- Packs
- 1 bottle
- Marketing authorisation holder
- Octapharma
- Manufacturer
- Octapharma
- Origin register
- US FDA, United States
- Storage
- Do not freeze. Store FIBRYGA for up to 48 months at +2°C to + 25°C (36°F to 77°F) from the date of manufacture. Store in the original container to protect from light. After reconstitution, do not refrigerate or freeze the FIBRYGA solution.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- B02BB01 Fibrinogen
- HS code (indicative)
- 3002.12Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 20 December 2024
- Identifiers
- RxCUI 831506, 1947382DailyMed set ID e3422d2a-2cb6-6f49-0be7-cb960b3d5bd5NDC 68982-349, 68982-350Application BLA125612
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 bottle, glass in 1 carton / 50 mL in 1 bottle, glass | 68982-349-01 | Octapharma | 20 December 2024 |
| 1 bottle, glass in 1 carton / 100 mL in 1 bottle, glass | 68982-350-01 | Octapharma | 23 June 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Fibrinogen human
Clinical summary
Fibrinogen human is a human blood coagulation factor indicated for the treatment of acute bleeding episodes in pediatric and adult patients with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia, among other approved uses. MedsAcross supplies Fibrinogen human for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Fibrinogen humanFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- RiaSTAP prescribing information (CSL Behring) · U.S. National Library of Medicine, DailyMed
Need Fibryga 20 mg/mL powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.